Novavax Inc
NASDAQ:NVAX

Watchlist Manager
Novavax Inc Logo
Novavax Inc
NASDAQ:NVAX
Watchlist
Price: 13.01 USD -9.65% Market Closed
Updated: May 19, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement
|
Revenue Breakdown

Balance Sheet

1.4B
-25%
Assets
Growth Rates:
1 Year
-12%
3 Years
-48%
5 Years
+512%
7 Years
+274%
10 Years
+519%
2.2B
-12%
Liabilities
Growth Rates:
1 Year
-9%
3 Years
+42%
5 Years
+497%
7 Years
+469%
10 Years
+7 975%
-867.1m
-21%
Equity
Growth Rates:
1 Year
+3%
3 Years
-
5 Years
-476%
7 Years
-2 880%
10 Years
-

Balance Sheet Decomposition
Novavax Inc

1.4B
Assets
2.2B
Liabilities
1.4B
Assets
2.2B
Liabilities
Current Assets 727.1m
Cash & Short-Term Investments 480.6m
Receivables 21.4m
Other Current Assets 225.2m
Non-Current Assets 626.4m
PP&E 472.3m
Intangibles 123.2m
Other Non-Current Assets 31m
Current Liabilities 804.4m
Accounts Payable 57.7m
Accrued Liabilities 257.4m
Other Current Liabilities 489.3m
Non-Current Liabilities 1.4B
Long-Term Debt 223m
Other Non-Current Liabilities 1.2B

Balance Sheet
Novavax Inc

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
32
93
144
106
70
79
218
458
1 337
569
Cash
0
0
0
0
0
0
122
96
0
0
Cash Equivalents
32
93
144
106
70
79
96
362
1 337
569
Short-Term Investments
136
138
91
51
22
0
493
1 057
0
0
Total Receivables
11
2
0
0
0
8
262
455
82
297
Accounts Receivables
11
2
0
0
0
8
262
455
82
297
Other Receivables
0
0
0
0
0
0
0
0
0
0
Inventory
0
0
0
0
0
0
0
0
37
42
Other Current Assets
10
54
52
46
27
11
275
185
248
236
Total Current Assets
188
287
288
203
119
97
1 248
2 155
1 703
1 144
PP&E Net
20
32
40
36
28
18
188
269
401
491
PP&E Gross
20
32
40
36
28
18
188
269
401
491
Accumulated Depreciation
11
16
22
29
36
13
18
30
47
75
Intangible Assets
13
11
9
8
7
6
6
5
0
0
Goodwill
55
53
52
54
52
51
135
132
126
127
Other Long-Term Assets
1
3
5
2
2
1
5
17
29
35
Other Assets
55
53
52
54
52
51
135
132
126
127
Total Assets
276
N/A
386
+40%
394
+2%
303
-23%
208
-31%
173
-17%
1 583
+815%
2 577
+63%
2 259
-12%
1 797
-20%
Liabilities
Accounts Payable
13
12
6
6
9
3
54
127
217
133
Accrued Liabilities
19
27
30
35
25
21
146
705
608
418
Short-Term Debt
0
0
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
1
0
0
0
0
0
106
131
352
5
Other Current Liabilities
1
38
31
33
12
2
273
1 428
1 283
1 080
Total Current Liabilities
34
77
66
74
46
26
580
2 390
2 460
1 635
Long-Term Debt
0
0
316
318
319
321
362
324
198
224
Other Liabilities
12
17
17
13
11
13
14
215
235
655
Total Liabilities
46
N/A
93
+101%
400
+328%
404
+1%
376
-7%
359
-4%
955
+166%
2 928
+207%
2 893
-1%
2 514
-13%
Equity
Common Stock
2
3
3
3
4
0
1
1
1
1
Retained Earnings
493
650
930
1 114
1 299
1 432
1 874
3 618
4 276
4 821
Additional Paid In Capital
729
952
936
1 021
1 141
1 261
2 536
3 352
3 738
4 192
Treasury Stock
3
3
3
3
3
3
42
85
91
92
Other Equity
7
9
12
9
11
13
7
1
6
3
Total Equity
230
N/A
293
+27%
6
N/A
102
-1 749%
168
-65%
186
-11%
627
N/A
352
N/A
634
-80%
717
-13%
Total Liabilities & Equity
276
N/A
386
+40%
394
+2%
303
-23%
208
-31%
173
-17%
1 583
+815%
2 577
+63%
2 259
-12%
1 797
-20%
Shares Outstanding
Common Shares Outstanding
12
14
14
16
19
32
71
76
86
140

See Also

Summary
NVAX intrinsic value, competitors valuation, and company profile.
DCF Valuation
NVAX stock valuation using Discount Cash Flow valuation method.
Relative Valuation
NVAX stock valuation using valuation multiples.
Wall Street Estimates
NVAX price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
NVAX stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 138,500+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.